Only reason I am holding on is the fading hope of privatisation.Many probably doing the same. Once this is no longer believable it will definitely dive below 1.00
Outlook. Given the inelastic demand for healthcare, we expect the normalisation of world travel habits should benefit KPJ on the back of pent up demand from domestic and international patients. However, there might be short-term headwinds as Covid-19 services taper off.
IHH offers to buy Ramsay Sime hospital for RM 6.57 . Quite recently Ramsay Sime bought Manipal hospitals. It seems there are active corporate actions on hospital assets currently.
KPJ ceo left after about a year - ?reason. Former JCORP chairman charged with corruption. The replacement apparently died from cancer. All the bad vibes from this counter Waiting at 80cts.
sama sama ada bisnes, tapi hospital orang lain yg untung byk, kpj untung sikit saje, hospital orang lain ada pemegang saham besar yg hebat, saham kasi naik, kpj ada pemegang saham besar johor corp yg ada masalah, hutang banyak, tak ade wang, kononnya hospital "homegrown", aku orang melayu pun rasa malu
New president of KPJ was from airline industry. Does he know anything about healthcare. No wonder the company going south. I notice the pay of CEO is going up (around RM2mil) and board is getting bigger but share price on the downtrends for more than 5 yrs. except fo a short spike last year due to unfounded rumour. Just compare KPJ board and IHH board.
This stock behaves like a GLC because its owned by a Sultan. They (the royal family) will have some influence to get themselves into advantageous positions before it starts to move.
A better-than-expected recovery in patient volume and operational efficiency is bolstering KPJ Healthcare Bhd's prospects, even as it comes off a stellar set of financial results.
KPJ reported a core profit after tax and minority interest (Patami) of RM54.6mil in Q3, which was double that of the immediate preceding quarter.
The healthcare group declared an interim dividend of one sen, going ex on Dec 12, 2022, as compared with a payout of 0.3 sen in the same quarter last year.
According to Hong Leong Investment Bank (HLIB) Research, the results were above its and consensus expectations at 95% of full-year forecasts.
"The stellar results were achieved mainly due to stronger-than-expected recovery in hospital operations post-pandemic.
"We raise our FY22-24f earnings forecasts by 20-36%, to better reflect the strong rebound in patient volume and operational efficiency," said the research firm in a note.
It reiterated its "buy" call on KPJ while raising its target price to RM1.27 from RM1.13 previously.
"The debt repayment is expected to lower KPJ’s net gearing to 0.61x, from 0.68x. The proposed sale is expected to complete by 1Q23," said HLIB.
In a separate report, CGS-CIMB Research noted that patient volume and bed occupancy rates have surpassed even pre-pandemic levels, possibly owing to underlying demand and pent-up demand from patients who had deferred surgeries during the COvid lockdowns.
"Post-3Q22 results, we raise FY22-24 forecast core earnings per share by 8.6-27.4%, mainly to factor in lower opex and depreciation, as well as higher associates earnings.
"We raise our FY22-24F payout ratio assumption to 70%, leading to yields of 2.5-3%.
"Our target price rises to RM1.18, after our earnings upgrade and rolling over to 2024 forecast price-earnings of 32 times (still 10-year mean)," it added.
Through my own experience, never trust a doctor 100%, because they are human too. Avoid abusing our own health is the best medicine and prevention from falling sick.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
freddiehero
16,662 posts
Posted by freddiehero > 2022-02-19 18:42 | Report Abuse
kpj rili. steady..